{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:59:30Z","timestamp":1791082770130,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":942,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Chronic hepatitis B patients with high viral loads are at increased risk of cirrhosis and hepatocellular carcinoma (HCC). In patients with low viral loads, higher hepatitis B surface antigen (HBsAg) levels have been shown to predict HCC development. However, little is known about the difference in risk for other hepatitis B virus (HBV)-related adverse outcomes with varying HBsAg levels. A total of 1,068 Taiwanese hepatitis B e antigen (HBeAg)-negative HBV carriers with serum HBV DNA level &lt;2,000 IU\/mL at baseline were followed for a mean duration of 13.0 years. Patients were categorized based on their HBsAg levels, and the relationships between HBsAg level and development of HBeAg-negative hepatitis, hepatitis flare, and cirrhosis were investigated. Of the 1068 patients with low viral loads, 280 developed HBeAg-negative hepatitis, with an annual incidence rate of 2.0%. HBsAg level, but not HBV DNA level, was found to be a risk factor for HBeAg-negative hepatitis. Multivariate analysis showed that the adjusted hazard ratio in patients with an HBsAg level \u22651,000 versus &lt;1000 IU\/mL was 1.5 (95% confidence interval, 1.2\u20131.9). The positive correlation was present when evaluating other endpoints, including hepatitis flare and cirrhosis, and remained consistent when the study population was restricted to those with normal alanine aminotransferase (ALT) level at baseline. The annual incidence rate of HBeAg-negative hepatitis was lowered to 1.1% in patients with low levels of HBV DNA, HBsAg, and ALT.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>In HBeAg-negative patients with low viral loads and genotype B or C virus infection, a higher HBsAg level can predict disease progression. HBsAg &lt;1,000 IU\/mL in combination with low levels of HBV DNA and ALT help define minimal-risk HBV carriers.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26041","type":"journal-article","created":{"date-parts":[[2012,9,3]],"date-time":"2012-09-03T07:05:59Z","timestamp":1346655959000},"page":"441-450","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":222,"title":["Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads"],"prefix":"10.1097","volume":"57","author":[{"given":"Tai-Chung","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Hung","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-An","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Fang-Tzu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Shinn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20241201","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.8211155","article-title":"From hepatitis to hepatoma: lessons from type B viral hepatitis.","volume":"262","author":"Chen","year":"1993","journal-title":"Science"},{"key":"R2-5-20241201","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000074999","article-title":"Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan.","volume":"46","author":"Kao","year":"2003","journal-title":"Intervirology"},{"key":"R3-5-20241201","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection.","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"R4-5-20241201","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus infection.","volume":"2","author":"Kao","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R5-5-20241201","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/infdis\/jir687","article-title":"Serum hepatitis B virusDNA levels correlate with longterm adverse outcomes in spontaneous hepatitis B e antigen seroconverters.","volume":"205","author":"Tseng","year":"2012","journal-title":"J Infect Dis"},{"key":"R6-5-20241201","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R7-5-20241201","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"R8-5-20241201","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1590-8658(10)60686-X","article-title":"Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis.","volume":"43","author":"Villa","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R9-5-20241201","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"R10-5-20241201","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Longterm outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.","volume":"35","author":"Hsu","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R11-5-20241201","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/hep.22878","article-title":"Longterm outcome of hepatitis B e antigennegative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.","volume":"49","author":"Tai","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R12-5-20241201","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.gastro.2011.04.046","article-title":"Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis b e antigen seroconverters.","volume":"141","author":"Tseng","year":"2011","journal-title":"Gastroenterology"},{"key":"R13-5-20241201","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"key":"RU14-5-20241201","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1053\/j.gastro.2007.08.039","article-title":"Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.","volume":"133","author":"Chu","year":"2007","journal-title":"Gastroenterology"},{"key":"R15-5-20241201","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"AsianPacific consensus statement on the management of chronic hepatitis B: a 2012 update.","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"RU16-5-20241201","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s005350300025","article-title":"Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virusrelated cirrhosis.","volume":"38","author":"Hung","year":"2003","journal-title":"J Gastroenterol"},{"key":"RU17-5-20241201","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcu.1870210502","article-title":"Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study.","volume":"21","author":"Lin","year":"1993","journal-title":"J Clin Ultrasound"},{"key":"R18-5-20241201","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update.","volume":"53","author":"Bruix","year":"2011","journal-title":"HEPATOLOGY"},{"key":"RU19-5-20241201","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3851\/IMP1696","article-title":"Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.","volume":"15","author":"Su","year":"2010","journal-title":"Antivir Ther"},{"key":"RU20-5-20241201","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.24615","article-title":"Determinants of spontaneous surface antigen loss in hepatitis B e antigennegative patients with a low viral load.","volume":"55","author":"Tseng","year":"2012","journal-title":"HEPATOLOGY"},{"key":"R21-5-20241201","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2004.06.031","article-title":"Quantification and genotyping of hepatitis B virus in a single reaction by realtime PCR and melting curve analysis.","volume":"41","author":"Yeh","year":"2004","journal-title":"J Hepatol"},{"key":"R22-5-20241201","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/gast.2003.50003","article-title":"A prospective study characterizing fulllength hepatitis B virus genomes during acute exacerbation.","volume":"124","author":"Liu","year":"2003","journal-title":"Gastroenterology"},{"key":"RU23-5-20241201","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12072-007-9002-9","article-title":"Spontaneous relapse of hepatitis in inactive HBsAg carriers.","volume":"1","author":"Chu","year":"2007","journal-title":"Hepatol Int"},{"key":"RU24-5-20241201","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009.","volume":"50","author":"Lok","year":"2009","journal-title":"HEPATOLOGY"},{"key":"RU25-5-20241201","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1053\/j.gastro.2010.01.042","article-title":"Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liverrelated death.","volume":"138","author":"Chen","year":"2010","journal-title":"Gastroenterology"},{"key":"RU26-5-20241201","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.23803","article-title":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B.","volume":"52","author":"Chan","year":"2010","journal-title":"HEPATOLOGY"},{"key":"RU27-5-20241201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection.","volume":"57","year":"2012","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26041","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:06:38Z","timestamp":1733061998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26041","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}